Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-10-29
1998-10-27
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
058278885
ABSTRACT:
A method of using allosteric hemoglobin modifier compounds which promote the release of oxygen to improve delivery of oxygen from the mother to the fetus and the release of oxygen to tissues from fetal hemoglobin in treatment of maternal and fetal related syndromes.
REFERENCES:
patent: 5122539 (1992-06-01), Abraham et al.
patent: 5290803 (1994-03-01), Abraham et al.
patent: 5432191 (1995-07-01), Abraham et al.
patent: 5525630 (1996-06-01), Hoffman et al.
patent: 5648375 (1997-07-01), Abraham
patent: 5677330 (1997-10-01), Abraham et al.
Abraham Donald J.
Gerber Michael J.
Cook Rebecca
The Center for Innovative Technology
LandOfFree
Perinatal treatment of a fetus to avoid oxygen deprivation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Perinatal treatment of a fetus to avoid oxygen deprivation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Perinatal treatment of a fetus to avoid oxygen deprivation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1614253